Skip to main content

Opioid Medications in the Management of Chronic Abdominal Pain

Current Pain and Headache Reports volume 21, Article number: 40 (2017) Cite this article

Abstract

Purpose of Review

Chronic abdominal pain is a complex medical condition. The causes of chronic abdominal pain are extremely diverse ranging from chronic pancreatitis, Crohn’s disease, to chronic pain with no clear etiology. Treatment of chronic abdominal pain remains a challenge in our clinical practice. While current interventions with celiac plexus blocks and pain medications provide some relief for these patients, but these treatments are typically less efficacious and limited by various adverse effects. Opioid medications are commonly used to manage chronic pain syndromes that are refectory to other pain management interventions. The potential problems related to opioids include misuse, abuse, constipation, nausea pruritus, et al. Moreover, according to the recent centers for disease (CDC) control report, opioid abuse has reached epidemic proportions in the USA (LJ P. Centers for Disease Control and Prevention. 2016) and accounted for 28,000 deaths in 2014. Rudd et al. (MMWR Morb Mortal Wkly Rep 64(50–51):1378–82, 2016) Given this current situation, it is apparent that a careful review of clinical evidences supporting the use of opioid medications is necessary to guide our treatment approaches in the management of complex chronic abdominal pain patients. This review is set out to analyze efficacy of opioid medications for chronic abdominal pain.

Recent Findings

The literature referenced was obtained via a computer search with Google Scholar, Pubmed, Medline, and EMbase. The search terms used included Opioid, Oxycodone, Buprenorphine, Morphine, Fentanyl, Oxymorphone, Hydromorphone, chronic abdominal pain, Crohn’s disease, and pancreatitis. All studies were considered eligible for inclusion if they were clinical studies evaluating the efficacy of opioid medications for chronic abdominal pain. Two studies were found according to these criteria.

Summary

Chronic abdominal pain is a challenging medical condition in our daily practice. This condition often requires opioid medications when other treatments fail. This review provided very limited clinical evidence to support long-term opioid use for chronic abdominal pain. Given recent CDC report of opioid epidemic, it is prudent to use the best medical practice with appropriate evaluation of psychological comorbidities, urine drug screening, prescription drug monitor, and opioid treatment agreements to minimize adverse side effects related to opioids. Furthermore, well-designed clinical trials are needed to evaluate the effectiveness of long-term use of opioid medications, and more clinical research on which opioid medication is more effective for chronic abdominal pain.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

43,34 €

Price includes VAT (Finland)
Tax calculation will be finalised during checkout.

References

  1. Ammann RW, Buehler H, Muench R, Freiburghaus AW, Siegenthaler W. Differences in the natural history of idiopathic (nonalcoholic) and alcoholic chronic pancreatitis. A comparative long-term study of 287 patients. Pancreas. 1987;2(4):368–77.

    CAS  Article  PubMed  Google Scholar 

  2. Bradley EL 3rd. Pancreatic duct pressure in chronic pancreatitis. Am J Surg. 1982;144(3):313–6.

    Article  PubMed  Google Scholar 

  3. Makrauer FL, Antonioli DA, Banks PA. Duodenal stenosis in chronic pancreatitis: clinicopathological correlations. Dig Dis Sci. 1982;27(6):525–32.

    CAS  Article  PubMed  Google Scholar 

  4. Bielefeldt K, Davis B, Binion DG. Pain and inflammatory bowel disease. Inflamm Bowel Dis. 2009;15(5):778–88. doi:10.1002/ibd.20848.

    Article  PubMed  PubMed Central  Google Scholar 

  5. Siegel CA, MacDermott RP. Is chronic pain an extraintestinal manifestation of IBD? Inflamm Bowel Dis. 2009;15(5):769–71. doi:10.1002/ibd.20844.

    Article  PubMed  Google Scholar 

  6. Cross RK, Wilson KT, Binion DG. Narcotic use in patients with Crohn’s disease. Am J Gastroenterol. 2005;100(10):2225–9. doi:10.1111/j.1572-0241.2005.00256.x.

    Article  PubMed  Google Scholar 

  7. Edwards JT, Radford-Smith GL, Florin TH. Chronic narcotic use in inflammatory bowel disease patients: prevalence and clinical characteristics. J Gastroenterol Hepatol. 2001;16(11):1235–8.

    CAS  Article  PubMed  Google Scholar 

  8. Grover M, Herfarth H, Drossman DA. The functional-organic dichotomy: postinfectious irritable bowel syndrome and inflammatory bowel disease-irritable bowel syndrome. Clin Gastroenterol Hepatol. 2009;7(1):48–53. doi:10.1016/j.cgh.2008.08.032.

    Article  PubMed  Google Scholar 

  9. LJ P. Prescription drug overdose: a US epidemic. Centers for Disease Control and Prevention. CDC Grand Rounds. May 23, 2016.

  10. Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths—United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–82. doi:10.15585/mmwr.mm6450a3.

    Article  PubMed  Google Scholar 

  11. Niemann T, Madsen LG, Larsen S, Thorsgaard N. Opioid treatment of painful chronic pancreatitis. Int J Pancreatol. 2000;27(3):235–40.

    CAS  Article  PubMed  Google Scholar 

  12. Sanford D, Thornley P, Teriaky A, Chande N, Gregor J. Opioid use is associated with decreased quality of life in patients with Crohn’s disease. Saudi J Gastroenterol. 2014;20(3):182–7. doi:10.4103/1319-3767.133020.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Aqua K, Gimbel JS, Singla N, Ma T, Ahdieh H, Kerwin R. Efficacy and tolerability of oxymorphone immediate release for acute postoperative pain after abdominal surgery: a randomized, double-blind, active- and placebo-controlled, parallel-group trial. Clin Ther. 2007;29(6):1000–12. doi:10.1016/j.clinthera.2007.06.001.

    CAS  Article  PubMed  Google Scholar 

  14. Singla N, Pong A, Newman K, Group MDS. Combination oxycodone 5 mg/ibuprofen 400 mg for the treatment of pain after abdominal or pelvic surgery in women: a randomized, double-blind, placebo- and active-controlled parallel-group study. Clin Ther. 2005;27(1):45–57. doi:10.1016/j.clinthera.2005.01.010.

    CAS  Article  PubMed  Google Scholar 

  15. Basurto Ona X, Rigau Comas D, Urrutia G. Opioids for acute pancreatitis pain. Cochrane Database Syst Rev. 2013;7:CD009179. doi:10.1002/14651858.CD009179.pub2.

    Google Scholar 

  16. Boudreau D, Von Korff M, Rutter CM, Saunders K, Ray GT, Sullivan MD, et al. Trends in long-term opioid therapy for chronic non-cancer pain. Pharmacoepidemiol Drug Saf. 2009;18(12):1166–75. doi:10.1002/pds.1833.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Furlan A, Chaparro LE, Irvin E, Mailis-Gagnon A. A comparison between enriched and nonenriched enrollment randomized withdrawal trials of opioids for chronic noncancer pain. Pain Res Manag. 2011;16(5):337–51.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Gordon A, Callaghan D, Spink D, Cloutier C, Dzongowski P, O'Mahony W, et al. Buprenorphine transdermal system in adults with chronic low back pain: a randomized, double-blind, placebo-controlled crossover study, followed by an open-label extension phase. Clin Ther. 2010;32(5):844–60. doi:10.1016/j.clinthera.2010.04.018.

    CAS  Article  PubMed  Google Scholar 

  19. Hale M, Khan A, Kutch M, Li S. Once-daily OROS hydromorphone ER compared with placebo in opioid-tolerant patients with chronic low back pain. Curr Med Res Opin. 2010;26(6):1505–18. doi:10.1185/03007995.2010.484723.

    CAS  Article  PubMed  Google Scholar 

  20. Tennant F. Why oral opioids may not be effective in a subset of chronic pain patients. Postgrad Med. 2016;128(1):18–22. doi:10.1080/00325481.2016.1128306.

    Article  PubMed  Google Scholar 

  21. Farmer AD, Ferdinand E, Aziz Q. Opioids and the gastrointestinal tract—a case of narcotic bowel syndrome and literature review. J Neurogastroenterol Motil. 2013;19(1):94–8. doi:10.5056/jnm.2013.19.1.94.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Drossman D, Szigethy E. The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl. 2014;2(1):22–30. doi:10.1038/ajgsup.2014.6.

    CAS  Article  PubMed  Google Scholar 

  23. OL KS. When should narcotic bowel syndrome be suspected? US Pharm. 2011;36:41–4.

    Google Scholar 

  24. Grunkemeier DM, Cassara JE, Dalton CB, Drossman DA. The narcotic bowel syndrome: clinical features, pathophysiology, and management. Clin Gastroenterol Hepatol. 2007;5(10):1126–1139; quiz 1-2. doi:10.1016/j.cgh.2007.06.013.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  25. Choung RS, Locke GR 3rd, Zinsmeister AR, Schleck CD, Talley NJ. Psychosocial distress and somatic symptoms in community subjects with irritable bowel syndrome: a psychological component is the rule. Am J Gastroenterol. 2009;104(7):1772–9. doi:10.1038/ajg.2009.239.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Chitkara DK, van Tilburg MA, Blois-Martin N, Whitehead WE. Early life risk factors that contribute to irritable bowel syndrome in adults: a systematic review. Am J Gastroenterol. 2008;103(3):765–774; quiz 75. doi:10.1111/j.1572-0241.2007.01722.x.

    Article  PubMed  Google Scholar 

  27. Rome JD, Townsend CO, Bruce BK, Sletten CD, Luedtke CA, Hodgson JE. Chronic noncancer pain rehabilitation with opioid withdrawal: comparison of treatment outcomes based on opioid use status at admission. Mayo Clin Proc. 2004;79(6):759–68. doi:10.4065/79.6.759.

    CAS  Article  PubMed  Google Scholar 

  28. Sullivan MD, Edlund MJ, Fan MY, Devries A, Brennan Braden J, Martin BC. Trends in use of opioids for non-cancer pain conditions 2000-2005 in commercial and Medicaid insurance plans: the TROUP study. Pain. 2008;138(2):440–9. doi:10.1016/j.pain.2008.04.027.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Olsen Y, Daumit GL, Ford DE. Opioid prescriptions by U.S. primary care physicians from 1992 to 2001. J Pain. 2006;7(4):225–35. doi:10.1016/j.jpain.2005.11.006.

    Article  PubMed  Google Scholar 

  30. Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ. Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain. Ann Intern Med. 2010;152(11):712–20. doi:10.7326/0003-4819-152-11-201006010-00004.

    Article  PubMed  Google Scholar 

  31. Volkow ND, McLellan TA. Curtailing diversion and abuse of opioid analgesics without jeopardizing pain treatment. JAMA. 2011;305(13):1346–7. doi:10.1001/jama. 2011.369.

    CAS  Article  PubMed  Google Scholar 

  32. Warner MCL, Makuc DM, Anderson RN. Drug poisoning deaths in the United States, 1980 –2008. NCHS Data Brief. 2011:1–8.

  33. Toblin RL, Paulozzi LJ, Logan JE, Hall AJ, Kaplan JA. Mental illness and psychotropic drug use among prescription drug overdose deaths: a medical examiner chart review. J Clin Psychiatry. 2010;71(4):491–6. doi:10.4088/JCP.09m05567blu.

    Article  PubMed  Google Scholar 

  34. Solanki DR, Koyyalagunta D, Shah RV, Silverman SM, Manchikanti L. Monitoring opioid adherence in chronic pain patients: assessment of risk of substance misuse. Pain Physician. 2011;14(2):E119–31.

    PubMed  Google Scholar 

  35. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85–92. doi:10.7326/0003-4819-152-2-201001190-00006.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Katz N, Fanciullo GJ. Role of urine toxicology testing in the management of chronic opioid therapy. Clin J Pain. 2002;18(4 Suppl):S76–82.

    Article  PubMed  Google Scholar 

  37. Katz NP, Sherburne S, Beach M, Rose RJ, Vielguth J, Bradley J, et al. Behavioral monitoring and urine toxicology testing in patients receiving long-term opioid therapy. Anesth Analg. 2003;97(4):1097–102. table of contents

    CAS  Article  PubMed  Google Scholar 

  38. Manchikanti L, Whitfield E, Pallone F. Evolution of the National All Schedules Prescription Electronic Reporting Act (NASPER): a public law for balancing treatment of pain and drug abuse and diversion. Pain Physician. 2005;8(4):335–47.

    PubMed  Google Scholar 

  39. Wang J, Christo PJ. The influence of prescription monitoring programs on chronic pain management. Pain Physician. 2009;12(3):507–15.

    PubMed  Google Scholar 

  40. Manchikanti L, Manchukonda R, Pampati V, Damron KS, Brandon DE, Cash KA, et al. Does random urine drug testing reduce illicit drug use in chronic pain patients receiving opioids? Pain Physician. 2006;9(2):123–9.

    PubMed  Google Scholar 

  41. Manchikanti L, Boswell MV, Singh V. Monitoring of patients receiving long-term opioid therapy. Anesth Analg. 2004;99(1):304. author reply -5

    Article  PubMed  Google Scholar 

  42. Roskos SE, Keenum AJ, Newman LM, Wallace LS. Literacy demands and formatting characteristics of opioid contracts in chronic nonmalignant pain management. J Pain. 2007;8(10):753–8. doi:10.1016/j.jpain.2007.01.005.

    Article  PubMed  Google Scholar 

  43. Arnold RM, Han PK, Seltzer D. Opioid contracts in chronic nonmalignant pain management: objectives and uncertainties. Am J Med. 2006;119(4):292–6. doi:10.1016/j.amjmed.2005.09.019.

    Article  PubMed  Google Scholar 

  44. Riviere PJ. Peripheral kappa-opioid agonists for visceral pain. Br J Pharmacol. 2004;141(8):1331–4. doi:10.1038/sj.bjp.0705763.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  45. Ross FB, Smith MT. The intrinsic antinociceptive effects of oxycodone appear to be kappa-opioid receptor mediated. Pain. 1997;73(2):151–7.

    CAS  Article  PubMed  Google Scholar 

  46. Eisenach JC, Carpenter R, Curry R. Analgesia from a peripherally active kappa-opioid receptor agonist in patients with chronic pancreatitis. Pain. 2003;101(1–2):89–95.

    CAS  Article  PubMed  Google Scholar 

  47. Staahl C, Dimcevski G, Andersen SD, Thorsgaard N, Christrup LL, Arendt-Nielsen L, et al. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol. 2007;42(3):383–90. doi:10.1080/00365520601014414.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information

Affiliations

  1. Jefferson Pain Center, Thomas Jefferson University Hospital, 834 Chestnut St. T150, Philadelphia, PA, 19107, USA

    Dajie Wang

Authors
  1. Dajie Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dajie Wang.

Ethics declarations

Conflict of Interest

Dajie Wang is a section editor for Current Pain and Headache Reports.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Anesthetic Techniques in Pain Management

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Wang, D. Opioid Medications in the Management of Chronic Abdominal Pain. Curr Pain Headache Rep 21, 40 (2017). https://doi.org/10.1007/s11916-017-0640-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11916-017-0640-x

Keywords

  • Chronic abdominal pain
  • Abdominal pain
  • Opioids
  • Opioid medications
  • Crohn’s disease
  • Chronic pancreatitis